Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

VIDEO: Mauna Kea Technologies' CEO, Sacha Loiseau, Ph.D., Featured in OTCQX Video Series

OTC Markets Group Inc.
Posted on: 22 Jan 18
VIDEO: Mauna Kea Technologies' CEO, Sacha Loiseau, Ph.D., Featured in OTCQX Video Series

PR Newswire

NEW YORK, Jan. 22, 2018

NEW YORK, Jan. 22, 2018 /PRNewswire/ -- Mauna Kea Technologies (OTCQX: MKEAY; MKEAF) CEO Sacha Loiseau was interviewed by OTC Markets Group (OTCQX: OTCM) in its prominent OTCQX® Video Series. The series features one-on-one interviews with senior executives of OTCQX companies as they showcase their businesses and investment profiles.

In the interview, Sacha Loiseau discusses:

  • The company's unique technology platform – digital optical biopsy, which enables doctors to bring a microscope inside the patient vs. taking a biopsy
  • The benefits of digital optical biopsy including a reduction in unnecessary procedures
  • The importance of the overall U.S. market, where the company's technology has received 13 different FDA clearances and is used in 150 hospitals

To watch the complete interview, visit OTC Markets Group's YouTube page at

About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer thanks to real time in vivo microscopic visualization. The Company's flagship product, Cellvizio, has received clearance to sell a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico. More than 580 systems are installed around the world and investigators have generated more than 1,000 publications on clinical applications of endomicroscopy.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities.  Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed

The information contained in this press release and in the video to which it refers is provided "as is" for educational and informational purposes only, and should not serve as the basis for any trading or investing decisions. OTC Markets Group makes no representations and disclaims all express, implied and statutory warranties of any kind to any viewer or third party.  Neither OTC Markets Group nor any of its affiliates makes any endorsement of any particular company, security, product or financial strategy, and nothing contained in this video should be construed as investment advice.  Investors should undertake their own diligence and carefully evaluate companies before investing.   

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428,



View original content with multimedia:

SOURCE OTC Markets Group Inc.

PR Newswire

Last updated on: 22/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.